Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

New series of 30-second PSAs on getting vaccinated against H1N1 flu

The U.S. Department of Health and Human Services (HHS), in conjunction with the Ad Council and the Jim Henson Company, has released a new series of 30-second public service announcements (PSAs) about the importance of getting the 2009 H1N1 vaccine. Targeted to parents and children, the PSA campaign features 15 governors, a state first lady, a state chief medical officer and the main character from the PBS’ series “Sid the Science Kid” and reminds the public that getting vaccinated is the best way to stay healthy during this flu season.

24 Dec 2009

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care provider in the U.S., announced today an expanded H1N1 vaccine outreach effort.

24 Dec 2009

Ligand Pharmaceuticals acquires Neurogen

Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.

23 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Thyroid cancer on the rise

As seen on "NBC Nightly News" Monday, December 21, the thyroid cancer rate is rising rapidly, especially among women. The American Thyroid Association's members are working to educate more people about thyroid cancer as well as treat and cure it.

23 Dec 2009

Gene's role in immune system may suggest new treatments for childhood asthma

Pediatric researchers have identified a novel gene involved in childhood asthma, in one of the largest gene studies to date of the common respiratory disease. Because the gene, called DENND1B, affects cells and signaling molecules thought to be instrumental in the immune system overreaction that occurs in asthma, the discovery may have singled out an important target for new treatments.

23 Dec 2009

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Rigel Pharmaceuticals, Inc. today announced that it has received a milestone payment from Daiichi Sankyo Co., Ltd. as part of their collaboration to research and develop cancer treatments aimed at selectively inhibiting ligases, which are intrinsic to cancer cell growth and proliferation. The compound, as yet unnamed, targets cell division.

23 Dec 2009

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published online today in the journal Psychosomatic Medicine.

23 Dec 2009

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.

23 Dec 2009

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

A McMaster University researcher has found the first evidence that prolonged exposure to higher levels of the pollutants found in car exhaust fumes and industrial air pollution can lead to hospitalization for pneumonia in adults aged 65 and older.

23 Dec 2009

Viron Therapeutics' three drug candidates granted U.S. patents

Viron Therapeutics Inc., a biotechnology company pioneering the development of virally-derived protein therapeutics, today announced that it has been granted U.S. patents related to three of its drug candidates, VT-111, VT-346 and VT-384.

23 Dec 2009

UV Flu Technologies introduces the UV 400 VIRAGUARD air purification product

UV Flu Technologies, Inc. wishes to advise it has recently acquired the assets of AmAirpure, Inc. in order to implement management's plans to move forward as an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality("IAQ") industry sector.

22 Dec 2009

New quantities of H1N1 vaccine available for walk-in patients; no appointments necessary

U.S. HealthWorks Medical Group, a leading operator of occupational health and urgent care centers in the nation, today announced that most of its 128 medical centers have new quantities of H1N1 vaccine available for walk-in patients – no appointments necessary.

22 Dec 2009

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.

21 Dec 2009

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.

19 Dec 2009

GSK receives European CHMP positive opinion for Revolade

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).

18 Dec 2009

Genetic variant associated with reduced risk of COPD

What: Researchers have discovered evidence that suggests a genetic variant may be associated with better preserved lung function among children with asthma and adults who smoke, according to a new study funded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health.

18 Dec 2009

Ligand Pharmaceuticals, Neurogen revise merger agreement

Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable

18 Dec 2009

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus -- in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.

17 Dec 2009

E Cigarettes National: Special interest groups have no legitimate argument against the cigarette

Over the last few weeks there has been an increase of the amount of scare language that is used by e cigarette opposition in an attempt to scare the population concerning the electronic cigarette. Many are questioning the tactics of these groups when the evidence clearly shows that the product is indeed a safer alternative to tobacco according to several studies, lab reports and opinions from top medial and harm reduction specialist around the world.

17 Dec 2009

Asthma News and Research

Further Reading

New series of 30-second PSAs on getting vaccinated against H1N1 flu

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

Ligand Pharmaceuticals acquires Neurogen

Majority of Australians think H1N1 vaccination is not necessary

Thyroid cancer on the rise

Gene's role in immune system may suggest new treatments for childhood asthma

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

Viron Therapeutics' three drug candidates granted U.S. patents

UV Flu Technologies introduces the UV 400 VIRAGUARD air purification product

New quantities of H1N1 vaccine available for walk-in patients; no appointments necessary

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

GSK receives European CHMP positive opinion for Revolade

Genetic variant associated with reduced risk of COPD

Ligand Pharmaceuticals, Neurogen revise merger agreement

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

E Cigarettes National: Special interest groups have no legitimate argument against the cigarette

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News